𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy

✍ Scribed by A Hong Kong Tuberculosis Treatment Services/British Medical Research Council Investigation

Book ID
108681523
Publisher
John Wiley and Sons
Year
1974
Tongue
English
Weight
710 KB
Volume
4
Category
Article
ISSN
0954-7894

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy and safety of a new combination
Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial
✍ L. Guenther; F. Cambazard; P.C.M. Van De Kerkhof; E. Snellman; K. Kragballe; A. πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 124 KB

## Background: Calcipotriol and betamethasone dipropionate are both widely used, effective treatments for psoriasis. vitamin d analogues and topical corticosteroids have different mechanisms of action in the treatment of psoriasis. a new vehicle has been developed in order to contain both calcipotr

The effect of moderate-dose corticostero
The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: Findings of a prospective, randomized, double-blind, placebo-controlled trial
✍ Chung-E Tseng; Jill P. Buyon; Mimi Kim; H. Michael Belmont; Meggan Mackay; Betty πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 2 views

## Abstract ## Objective Serial measurements of anti–double‐stranded DNA (anti‐dsDNA) and complement are routine in the management of systemic lupus erythematosus (SLE), but their utility as biomarkers in preemptive treatment to prevent flares remains a subject of controversy. We hypothesized that